CONSTITUTIVE EXPRESSION OF B-MYB CAN BYPASS P53-INDUCED WAF1/CIP1-MEDIATED G(1) ARREST

被引:119
作者
LIN, D
FISCELLA, M
OCONNOR, PM
JACKMAN, J
CHEN, M
LUO, LL
SALA, A
TRAVALI, S
APPELLA, E
MERCER, WE
机构
[1] THOMAS JEFFERSON UNIV, JEFFERSON CANC INST, DEPT MICROBIOL & IMMUNOL, PHILADELPHIA, PA 19170 USA
[2] THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19170 USA
[3] NCI, CELL BIOL LAB, BETHESDA, MD 20892 USA
[4] NCI, DIV CANC TREATMENT, MOLEC PHARMACOL LAB, BETHESDA, MD 20892 USA
关键词
ONCOGENE; SUPPRESSOR GENE; CELL CYCLE;
D O I
10.1073/pnas.91.21.10079
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Overexpression of wild-type p53 protein has been shown to induce arrest ih the G(1) stage of the cell cycle and to transactivate expression of the gene that encodes the 21-kDa Waf1/Cip1 protein, a potent inhibitor of cyclin-dependent kinase activity, p53-dependent G(1) arrest is accompanied by decreased expression of the B-myb gene, a relative of the c-myb cellular oncogene. In this study we show that B-myb expression is required for cells to progress from G(1) into S phase and that high levels of ectopic B-myb expression uncoupled from cell cycle regulation rescues cells from p53-induced G(1) arrest even in the presence of Waf1/Cip1 transactivation and inhibition of cyclin E/Cdk2 kinase activity. Cotransfection experiments with p53 expression plasmids and expression plasmids encoding in-frame deletion mutations in B-myb coding sequences indicate that the DNA-binding domain of the B-myb protein is required for this activity. These results provide evidence of a bypass of p53-induced Waf1/Cip1-mediated cell cycle regulatory pathways by a member of the myb oncogene family.
引用
收藏
页码:10079 / 10083
页数:5
相关论文
共 40 条
  • [1] ARSURA M, 1992, BLOOD, V79, P2708
  • [2] CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS
    BAKER, SJ
    FEARON, ER
    NIGRO, JM
    HAMILTON, SR
    PREISINGER, AC
    JESSUP, JM
    VANTUINEN, P
    LEDBETTER, DH
    BARKER, DF
    NAKAMURA, Y
    WHITE, R
    VOGELSTEIN, B
    [J]. SCIENCE, 1989, 244 (4901) : 217 - 221
  • [3] CALABRETTA B, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P225
  • [4] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [5] CELL CYCLE-SPECIFIC ASSOCIATION OF E2F WITH THE P130 E1A-BINDING PROTEIN
    COBRINIK, D
    WHYTE, P
    PEEPER, DS
    JACKS, T
    WEINBERG, RA
    [J]. GENES & DEVELOPMENT, 1993, 7 (12A) : 2392 - 2404
  • [6] P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS
    DILLER, L
    KASSEL, J
    NELSON, CE
    GRYKA, MA
    LITWAK, G
    GEBHARDT, M
    BRESSAC, B
    OZTURK, M
    BAKER, SJ
    VOGELSTEIN, B
    FRIEND, SH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) : 5772 - 5781
  • [7] THE TUMOR-SUPPRESSOR P53
    DONEHOWER, LA
    BRADLEY, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1155 (02) : 181 - 205
  • [8] P53-DEPENDENT INHIBITION OF CYCLIN-DEPENDENT KINASE-ACTIVITIES IN HUMAN FIBROBLASTS DURING RADIATION-INDUCED G1 ARREST
    DULIC, V
    KAUFMANN, WK
    WILSON, SJ
    TLSTY, TD
    LEES, E
    HARPER, JW
    ELLEDGE, SJ
    REED, SI
    [J]. CELL, 1994, 76 (06) : 1013 - 1023
  • [9] ELDEIRY WS, 1994, CANCER RES, V54, P1169
  • [10] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825